Eye-minders
Products to Enhance Safety and Based on Eye-movement Analysis.
Company Overview
Snapshot
Founded in October 2017 by Daphna Palti-Wasserman, Eye-minders operates with 1–10 employees. The company has raised $5.8 million across one funding round from one investor. Eye-minders is expanding into clinical mental health, building on its established credibility assessment product.
Business overview
Eye-minders is a deep-tech company that develops patented AI algorithms to analyze eye movements and pupil dynamics, extracting biomarkers for cognitive and emotional load. Its core technology is applied in a commercial product for credibility assessment, currently utilized by private companies and government agencies. The company is expanding its focus into clinical mental health, with initiatives such as a PTSD diagnostics pilot in collaboration with leading hospitals. Eye-minders operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare, Digital Medical Diagnostics, and Digital Therapeutics, serving both healthcare providers and consumers.
Strategic signal
In March 2024, Eye-minders was featured in CTech for its innovative approach to understanding a person's inner world through eye analysis. This highlights the company's progress in leveraging its patented AI algorithms for broader applications beyond its initial credibility assessment product, signaling potential for significant impact in mental health diagnostics and a strong validation of its deep-tech capabilities.
Log in to access full profile ›Company Intelligence Q&A
- What is Eye-minders' core technology?
- Eye-minders develops patented AI algorithms that analyze eye movements and pupil dynamics to extract biomarkers of cognitive and emotional load, forming the basis of its deep-tech solutions.
- When was Eye-minders founded and by whom?
- Eye-minders was founded in October 2017 by Daphna Palti-Wasserman, who serves as the Founder & CEO.
- What is Eye-minders' primary market focus?
- Eye-minders initially focused on credibility assessment for private companies and government agencies and is now expanding into clinical mental health, particularly in areas like PTSD diagnostics.
- How much capital has Eye-minders raised?
- Eye-minders has raised a total of $5.8 million across one funding round.
- What significant clinical initiative is Eye-minders involved in?
- Eye-minders was selected by MAFAAT (Israel’s Directorate of Defense R&D) to lead a PTSD diagnostics pilot in collaboration with leading hospitals, including Sheba Medical Center, marking its first clinical initiative.